Announcements Trials
Browse Landscape

Phase

Phase 2 115Phase 1 32Phase 3 31Phase 1/2 20Phase 4 6Phase NA 3Phase EARLY_PHASE1 2Phase 2/3 2

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1

Conditions

Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone 1Prostatic Neoplasms 1Pharmacogenetic Study 1

Interventions

Exercise 439Blood Specimen Collection 333Standard of Care 321Magnetic Resonance Spectroscopy 258Radiotherapy 255Surveys and Questionnaires 245Radiosurgery 245Educational Status 230Methods 229Early Intervention, Educational 218Practice Guidelines as Topic 146Interviews as Topic 146Biopsy 145Surgical Procedures, Operative 134Drug Therapy 133Control Groups 128Acupuncture Therapy 124Therapeutics 110Cyclophosphamide 103Palliative Care 101Counseling 101Resistance Training 95Saline Solution 90Cisplatin 90Magnetic Resonance Imaging 89Radiofrequency Ablation 86Radiotherapy, Intensity-Modulated 79Colonoscopy 79Specimen Handling 78Cognitive Behavioral Therapy 72

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Interventional × Abiraterone Acetate × Clear all
NCT01961843 2025-11-25

Abiraterone Acetate for Castrate Resistant Prostate Cancer

Massachusetts General Hospital

Phase NA Completed
40 enrolled
Genitourinary

Prostatic Neoplasms

NCT01858441 2020-12-04

ABIGENE

Centre Antoine Lacassagne

Phase NA Completed
148 enrolled

Pharmacogenetic Study

NCT03449719 2018-02-28

ARTO

Azienda Ospedaliero-Universitaria Careggi

Phase NA Unknown
174 enrolled

Rate of PSA Response in Oligometastatic,CRPC Undergoing SBRT in Combination With Abiraterone Acetate (AA), Compared to Patients Treated With AA Alone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡